1.
Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy
by Ridderstråle, Wilhelm
Hypertension (Dallas, Tex. 1979), 2006, Vol.47 (4), p.686-691
2.
Management of Antiangiogenic Therapy-Induced Hypertension
by de Jesus-Gonzalez, Nilka
Hypertension (Dallas, Tex. 1979), 2012, Vol.60 (3), p.607-615
3.
Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study
by Bang, Casper N
American journal of hypertension, 2017, Vol.30 (9), p.914-922
4.
CYP4A2-Induced Hypertension Is 20-Hydroxyeicosatetraenoic Acid- and Angiotensin II-Dependent
by Sodhi, Komal
Hypertension (Dallas, Tex. 1979), 2010, Vol.56 (5), p.871-878
5.
Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA–salt hypertension-induced vascular dementia in rats
by Sharma, Bhupesh
Psychopharmacologia, 2012, Vol.223 (3), p.307-317
6.
Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Results by Sex
by Oparil, Suzanne
Hypertension (Dallas, Tex. 1979), 2013, Vol.61 (5), p.977-986
7.
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
by Rouleau, Jean L
The Lancet (British edition), 2000, Vol.356 (9230), p.615-620
8.
Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Low...
by Leenen, Frans H.H
Hypertension (Dallas, Tex. 1979), 2006, Vol.48 (3), p.374-384
9.
Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat
by Wilkinson-Berka, J. L
Diabetologia, 2011, Vol.54 (10), p.2724-2735
10.
Assessing Medication Adherence Simultaneously by Electronic Monitoring and Pill Count in Patients With Mild-to-Moderate Hypertension
by van Onzenoort, Hein A.W.
American journal of hypertension, 2010, Vol.23 (2), p.149-154
11.
Skeletal muscle magnesium content is correlated with plasma glucose concentration in patients with essential hypertension treated with lisinopril or bendrofluazide
by Haenni, Arvo
American journal of hypertension, 2002, Vol.15 (8), p.735-738
12.
Vasopeptidase inhibition and angio-oedema
by Messerli, Franz H
The Lancet (British edition), 2000, Vol.356 (9230), p.608-609
13.
Lisinopril for the Treatment of Hypertension Within the First 24 Hours of Acute Ischemic Stroke and Follow-Up
by Eveson, David J
American journal of hypertension, 2007, Vol.20 (3), p.270-277
14.
Blood Pressure Control in Hispanics in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
by Margolis, Karen L
Hypertension (Dallas, Tex. 1979), 2007, Vol.50 (5), p.854-861
15.
Pet ownership, but not ACE inhibitor therapy, blunts home blood pressure responses to mental stress
by ALLEN, Karen
Hypertension (Dallas, Tex. 1979), 2001, Vol.38 (4), p.815-820
16.
The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) heart failure Validation Study: Diagnosis and prognosis
by Einhorn, Paula T., MD, MS
The American heart journal, 2007, Vol.153 (1), p.42-53
17.
Antihypertensive Therapy Increases Cerebral Blood Flow and Carotid Distensibility in Hypertensive Elderly Subjects
by Lipsitz, Lewis A
Hypertension (Dallas, Tex. 1979), 2005, Vol.45 (2), p.216-221
18.
Cerebrovascular Support for Cognitive Processing in Hypertensive Patients Is Altered by Blood Pressure Treatment
by Jennings, J Richard
Hypertension (Dallas, Tex. 1979), 2008, Vol.52 (1), p.65-71
19.
Effects of Celecoxib on Ambulatory Blood Pressure in Hypertensive Patients on ACE Inhibitors
by White, William B
Hypertension (Dallas, Tex. 1979), 2002, Vol.39 (4), p.929-934
20.
A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension
by Hogg, Ronald J
Pediatric nephrology (Berlin, West), 2007, Vol.22 (5), p.695-701
